The genetic basis of female reproductive disorders: Etiology and clinical testing

Molecular and Cellular Endocrinology

Volumn 370, Issue 1-2, 2013, Pages 138-148

  Layman, Lawrence C ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Endometriosis; Genetics of hypogonadism; Leiomyomata; Mullerian aplasia; Polycystic ovary syndrome; Spontaneous ovarian hyperstimulation syndrome

Indexed keywords

ESTRADIOL; ESTROGEN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; WNT4 PROTEIN;

CHD7 GENE; CHROMOSOMAL LOCALIZATION; ENDOMETRIOSIS; FGFR1 GENE; FUMARATE HYDRATASE GENE; GENE; GENE DELETION; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GNRH1 GENE; GYNECOLOGIC DISEASE; HORMONE DEFICIENCY; HORMONE RESISTANCE; HUMAN; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; HYPOPHYSIS; HYPOTHALAMUS; KAL1 GENE; KALLMANN SYNDROME; LEIOMYOMA; NONHUMAN; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROP1 GENE; REVIEW; ROKITANSKY SYNDROME; SINGLE NUCLEOTIDE POLYMORPHISM; WNT4 GENE;

46, XX DISORDERS OF SEX DEVELOPMENT; CONGENITAL ABNORMALITIES; DISORDERS OF SEX DEVELOPMENT; DNA HELICASES; DNA-BINDING PROTEINS; ENDOMETRIOSIS; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; GENITAL DISEASES, FEMALE; HOMEODOMAIN PROTEINS; HUMANS; HYPOGONADISM; LEIOMYOMA; MALE; MULLERIAN DUCTS; OVARIAN HYPERSTIMULATION SYNDROME; PITUITARY HORMONES, ANTERIOR; POLYCYSTIC OVARY SYNDROME; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; WNT4 PROTEIN;

EID: 84876397225     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.02.016     Document Type: Review

References (107)

1. Abreu A.P., Trarbach E.B., de Castro M., Frade Costa E.M., Versiani B., Matias Baptista M.T., et al. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome. J. Clin. Endocrinol. Metab. 2008, 93:4113-4118.
2. Aittomaki K., Lucena J.L., Pakarinen P., Sistonen P., Tapanainen J., Gromoll J., et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995, 82:959-968.
3. Allingham-Hawkins D.J., Babul-Hirji R., Chitayat D., Holden J.J., Yang K.T., Lee C., et al. Fragile X premutation is a significant risk factor for premature ovarian failure: the international collaborative POF in fragile X study-preliminary data. Am. J. Med. Genet. 1999, 83:322-325.
4. Azziz R., Carmina E., Dewailly D., Diamanti-Kandarakis E., Escobar-Morreale H.F., Futterweit W., et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J. Clin. Endocrinol. Metab. 2006, 91:4237-4245.
5. Barnes R.B., Namnoum A., Rosenfield R.L., Layman L.C. Effects of follicle-stimulating hormone on ovarian androgen production in a woman with isolated follicle-stimulating hormone deficiency. N. Engl. J. Med. 2000, 343:1197-1198.
6. Barnes R.B., Namnoum A., Rosenfield R.L., Layman L.C. The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: clinical studies in a patient with isolated FSH deficiency and multicystic ovaries. Hum. Reprod. 2002, 17:88-91.
7. Bentley G.E., Ubuka T., McGuire N.L., Calisi R., Perfito N., Kriegsfeld L.J., et al. Gonadotrophin-inhibitory hormone: a multifunctional neuropeptide. J. Neuroendocrinol. 2009, 21:276-281.
8. Bhagavath B., Ozata M., Ozdemir I.C., Bolu E., Bick D.P., Sherins R.J., et al. The prevalence of gonadotropin-releasing hormone receptor mutations in a large cohort of patients with hypogonadotropic hypogonadism. Fertil. Steril. 2005, 84:951-957.
9. Bhagavath B., Podolsky R.H., Ozata M., Bolu E., Bick D.P., Kulharya A., et al. Clinical and molecular characterization of a large sample of patients with hypogonadotropic hypogonadism. Fertil. Steril. 2006, 85:706-713.
10. Biason-Lauber A., Konrad D., Navratil F., Schoenle E.J. A WNT4 mutation associated with Mullerian-duct regression and virilization in a 46 XX woman. New Engl. J. Med. 2004, 351:792-798.
11. Bione S., Sala C., Manzini C., Arrigo G., Zuffardi O., Banfi S., et al. A human homologue of the drosophila melanogaster diaphenous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility. Am. J. Hum. Genet. 1998, 62:533-541.
12. Bouligand J., Ghervan C., Tello J.A., Brailly-Tabard S., Salenave S., Chanson P., et al. Isolated familial hypogonadotropic hypogonadism and a GNRH1 mutation. N. Engl. J. Med. 2009, 360:2742-2748.
13. Brown T.R., Lubahn D.B., Wilson E.M., Joseph D.R., French F.S., Migeon C.J. Deletion of the steroid-binding domain of the human androgen receptor gene in one family with complete androgen insensitivity syndrome: evidence for further genetic heterogeneity in this syndrome. Proc. Nat. Acad. Sci. 1988, 85:8151-8155.
14. Bulun S.E. Endometriosis. N. Engl. J. Med. 2009, 360:268-279.
15. Cha P.C., Takahashi A., Hosono N., Low S.K., Kamatani N., Kubo M., et al. A genome-wide association study identifies three loci associated with susceptibility to uterine fibroids. Nat. Genet. 2011, 43:447-450.
16. Chan, Y.M., de Guillebon, A., Lang-Muritano, M., Plummer, L., Cerrato, F., Tsiaras, S., et al., 2009. GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism. Proc. Natl. Acad. Sci. USA.
17. Cheng G., Coolen L.M., Padmanabhan V., Goodman R.L., Lehman M.N. The kisspeptin/neurokinin B/dynorphin (KNDy) cell population of the arcuate nucleus: sex differences and effects of prenatal testosterone in sheep. Endocrinology 2010, 151:301-311.
18. Clement K., Vaisse C., Lahlou N., Cabrol S., Pelloux V., Cassuto D., et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998, 392:398-401.
19. Consortium F.-G.A. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat. Genet. 1997, 17:399-403.
20. Conway G.S., Payne N.N., Webb J., Murray A., Jacobs P.A. Fragile X premutation screening in women with premature ovarian failure. Hum. Reprod. 1998, 13:1184-1187.
21. Crisponi L., Deiana M., Loi A., Chiappe F., Uda M., Amati P., et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat. Genet. 2001, 27:159-166.
22. de Roux N., Young J., Misrahi M., Genet R., Chanson P., Schaison G., et al. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N. Engl. J. Med. 1997, 337:1597-1602.
23. de Roux N., Genin E., Carel J.C., Matsuda F., Chaussain J.L., Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc. Natl. Acad. Sci. USA 2003, 100:10972-10976.
24. Di Pasquale E., Beck-Peccoz P., Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am. J. Hum. Genet. 2004, 75:106-111.
25. Dode C., Levilliers J., Dupont J.M., De Paepe A., Le Du N., Soussi-Yanicostas N., et al. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat. Genet. 2003, 33:463-465.
26. Dode C., Teixeira L., Levilliers J., Fouveaut C., Bouchard P., Kottler M.L., et al. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet. 2006, 2:e175.
27. Eggert S.L., Huyck K.L., Somasundaram P., Kavalla R., Stewart E.A., Lu A.T., et al. Genome-wide linkage and association analyses implicate FASN in predisposition to uterine leiomyomata. Am. J. Hum. Genet. 2012, 91:621-628.
28. Ewens K.G., Stewart D.R., Ankener W., Urbanek M., McAllister J.M., Chen C., et al. Family-based analysis of candidate genes for polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2010, 95:2306-2315.
29. Falardeau J., Chung W.C., Beenken A., Raivio T., Plummer L., Sidis Y., et al. Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J. Clin. Invest. 2008, 118:2822-2831.
30. Franco B., Guioli S., Pragliola A., Incerti B., Bardoni B., Tonlorenzi R., et al. A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 1991, 353:529-536.
31. Garg A. Clinical review#: lipodystrophies: genetic and acquired body fat disorders. J. Clin. Endocrinol. Metab. 2011, 96:3313-3325.
32. Gogusev J., Bouquet de Joliniere J., Telvi L., Doussau M., du Manoir S., Stojkoski A., et al. Detection of DNA copy number changes in human endometriosis by comparative genomic hybridization. Hum. Genet. 1999, 105:51-444.
33. Gottlieb B., Pinsky L., Beitel L.K., Trifiro M. Androgen insensitivity. Am. J. Med. Genet. 1999, 89:210-217.
34. Habiby R.L., Boepple P., Nachtigall L., Sluss P.M., Crowley W.F., Jameson J.L. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalmic and pituitary defects in gonadotropin production. J. Clin. Invest. 1996, 98:1055-1062.
35. Hanchate N.K., Giacobini P., Lhuillier P., Parkash J., Espy C., Fouveaut C., et al. SEMA3A, a gene involved in axonal pathfinding, is mutated in patients with Kallmann syndrome. PLoS Genet. 2012, 8:e1002896.
36. Hardelin J.P., Levilliers J., Blanchard S., Carel J.C., Leutenegger M., Pinard-Bertelletto J.P., et al. Heterogeneity in the mutations responsible for X chromosome-linked Kallmann syndrome. Hum. Mol. Genet. 1993, 2:373-377.
37. Hurley M.E., White M.J., Green A.J., Kelleher J. Antley-Bixler syndrome with radioulnar synostosis. Pediatr. Radiol. 2004, 34:148-151.
38. Ito Y., Fisher C.R., Conte F.A., Grumbach M.M., Simpson E.R. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc. Natl. Acad. Sci. USA 1993, 90:11673-11677.
39. Jager R.J., Anvret M., Hall K., Scherer G. A human XY female with a frame shift mutation in the candidate testis-determining gene SRY. Nature 1990, 348:452-454.
40. Kadowaki T., Bevins C.L., Cama A., Ojamaa K., Marcus-Samuels B., Kadowaki H., et al. Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science 1988, 240:787-790.
41. Kelberman D., Rizzoti K., Lovell-Badge R., Robinson I.C., Dattani M.T. Genetic regulation of pituitary gland development in human and mouse. Endocr. Rev. 2009, 30:790-829.
42. Kim H.G., Kurth I., Lan F., Meliciani I., Wenzel W., Eom S.H., et al. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am. J. Hum. Genet. 2008, 83:511-519.
43. Kim H.G., Bhagavath B., Layman L.C. Clinical manifestations of impaired GnRH neuron development and function. Neurosignals 2008, 16:165-182.
44. Kim H.G., Pedersen-White J., Bhagavath B., Layman L.C. Genotype and phenotype of patients with gonadotropin-releasing hormone receptor mutations. Front. Horm. Res. 2010, 39:94-110.
45. Kim H.G., Ahn J.W., Kurth I., Ullmann R., Kim H.T., Kulharya A., et al. WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am. J. Hum. Genet. 2010, 87:465-479.
46. Kress W., Petersen B., Collmann H., Grimm T. An unusual FGFR1 mutation (fibroblast growth factor receptor 1 mutation) in a girl with non-syndromic trigonocephaly. Cytogenet. Cell Genet. 2000, 91:138-140.
47. Laissue P., Lakhal B., Benayoun B.A., Dipietromaria A., Braham R., Elghezal H., et al. Functional evidence implicating FOXL2 in non-syndromic premature ovarian failure and in the regulation of the transcription factor OSR2. J. Med. Genet. 2009, 46:455-457.
48. Layman L.C. Genetics of human hypogonadotropic hypogonadism. Am. J. Med. Genet. 1999, 89:240-248.
49. Layman L.C. Human gene mutations causing infertility. J. Med. Genet. 2002, 39:153-161.
50. Layman L.C., Lee E.J., Peak D.B., Namnoum A.B., Vu K.V., van Lingen B.L., et al. Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone beta-subunit gene. N. Engl. J. Med. 1997, 337:607-611.
51. Layman L.C., Cohen D.P., Jin M., Xie J., Li Z., Reindollar R.H., et al. Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism. Nat. Genet. 1998, 18:14-15.
52. Legouis R., Hardelin J.P., Levilliers J., Claverie J.M., Compain S., Wunderle V., et al. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 1991, 67:423-435.
53. Lindner T.H., Njolstad P.R., Horikawa Y., Bostad L., Bell G.I., Sovik O. A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1beta. Hum. Mol. Genet. 1999, 8:2001-2008.
54. Lofrano-Porto A., Barra G.B., Giacomini L.A., Nascimento P.P., Latronico A.C., Casulari L.A., et al. Luteinizing hormone beta mutation and hypogonadism in men and women. N. Engl. J. Med. 2007, 357:897-904.
55. Lourenco D., Brauner R., Lin L., De Perdigo A., Weryha G., Muresan M., et al. Mutations in NR5A1 associated with ovarian insufficiency. N. Engl. J. Med. 2009, 360:1200-1210.
56. Lutz B., Karatani S., Rugarli E.I., Wawersik S., Wong C., Bieber F.R., et al. Expression of the Kallmann syndrome gene in human fetal brain and in the manipulated chick embryo. Hum. Mol. Genet. 1994, 3:1717-1723.
57. Makinen N., Mehine M., Tolvanen J., Kaasinen E., Li Y., Lehtonen H.J., et al. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science 2011, 334:252-255.
58. Mason A.J., Pitts S.L., Nikolics K., Szonyi E., Wilcox J.N., Seeburg P.H., et al. The hypogonadal mouse: reproductive functions restored by gene therapy. Science 1986, 234:1372-1378.
59. Matthews C.H., Borgato S., Beck-Peccoz P., Adams M., Tone Y., Gambin G., et al. Primary amenorrhea and infertility due to a mutation in the β-subunit of follicle-stimulating hormone. Nat. Genet. 1993, 5:83-86.
60. Muenke M., Schell U., Hehr A., Robin N.H., Losken H.W., Schinzel A., et al. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat. Genet. 1994, 8:269-274.
61. Muscatelli F., Strom T.M., Walker A.P., Zanaria E., Recan D., Meindl A., et al. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 1994, 372:672-676.
62. Nagamine K., Peterson P., Scott H.S., Kudoh J., Minoshima S., Heino M., et al. Positional cloning of the APECED gene. Nat. Genet. 1997, 17:393-398.
63. Nik-Zainal S., Strick R., Storer M., Huang N., Rad R., Willatt L., et al. High incidence of recurrent copy number variants in patients with isolated and syndromic Mullerian aplasia. J. Med. Genet. 2011, 48:197-204.
64. Ott J., Kamatani Y., Lathrop M. Family-based designs for genome-wide association studies. Nat. Rev. Genet. 2011, 12:465-474.
65. Painter J.N., Anderson C.A., Nyholt D.R., Macgregor S., Lin J., Lee S.H., et al. Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis. Nat. Genet. 2011, 43:51-54.
66. Pedersen-White J.R., Chorich L.P., Bick D.P., Sherins R.J., Layman L.C. The prevalence of intragenic deletions in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Mol. Hum. Reprod. 2008, 14:367-370.
67. Philibert P., Biason-Lauber A., Rouzier R., Pienkowski C., Paris F., Konrad D., et al. Identification and functional analysis of a new WNT4 gene mutation among 28 adolescent girls with primary amenorrhea and mullerian duct abnormalities: a French collaborative study. J. Clin. Endocrinol. Metab. 2008, 93:895-900.
68. Phillips J.A., Poling J.S., Phillips C.A., Stanton K.C., Austin E.D., Cogan J.D., et al. Synergistic heterozygosity for TGFbeta1 SNPs and BMPR2 mutations modulates the age at diagnosis and penetrance of familial pulmonary arterial hypertension. Genet. Med. 2008, 10:359-365.
69. Pitteloud N., Acierno J.S., Meysing A.U., Dwyer A.A., Hayes F.J., Crowley W.F. Reversible kallmann syndrome, delayed puberty, and isolated anosmia occurring in a single family with a mutation in the fibroblast growth factor receptor 1 gene. J. Clin. Endocrinol. Metab. 2005, 90:1317-1322.
70. Pitteloud N., Quinton R., Pearce S., Raivio T., Acierno J., Dwyer A., et al. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J. Clin. Invest. 2007, 117:457-463.
71. Plant T.M. Hypothalamic control of the pituitary-gonadal axis in higher primates: key advances over the last two decades. J. Neuroendocrinol. 2008, 20:719-726.
72. Qin Y., Choi Y., Zhao H., Simpson J.L., Chen Z.J., Rajkovic A. NOBOX homeobox mutation causes premature ovarian failure. Am. J. Hum. Genet. 2007, 81:576-581.
73. Quaynor S.D., Kim H.G., Cappello E.M., Williams T., Chorich L.P., Bick D.P., et al. The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome. Fertil. Steril. 2011, 96. 1424-30e6.
74. Quaynor SD, Submitted for publication.
75. Reindollar R.H., Byrd J.R., McDonough P.G. Delayed sexual development: study of 252 patients. Am. J. Obstet. Gynecol. 1981, 140:371-380.
76. Reindollar R.H., Novak M., Tho S.P.T., McDonough P.G. Adult-onset amenorrhea: a study of 262 patients. Am. J. Obstet. Gynecol. 1986, 155:531-543.
77. Roscioli T., Flanagan S., Kumar P., Masel J., Gattas M., Hyland V.J., et al. Clinical findings in a patient with FGFR1 P252R mutation and comparison with the literature. Am. J. Med. Genet. 2000, 93:22-28.
78. Rugarli E.I., Ballabio A. Kallmann syndrome. From genetics to neurobiology. JAMA 1993, 270:2713-2716.
79. Schuler A.M., Gower B.A., Matern D., Rinaldo P., Vockley J., Wood P.A. Synergistic heterozygosity in mice with inherited enzyme deficiencies of mitochondrial fatty acid beta-oxidation. Mol. Genet. Metab. 2005, 85:7-11.
80. Seminara S.B., Messager S., Chatzidaki E.E., Thresher R.R., Acierno J.S., Shagoury J.K., et al. The GPR54 gene as a regulator of puberty. N. Engl. J. Med. 2003, 349:1614-1627.
81. Shi Y., Zhao H., Cao Y., Yang D., Li Z., Zhang B., et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat. Genet. 2012, 44:1020-1025.
82. Siegel E.T., Kim H.G., Nishimoto H.K., Layman L.C. The molecular basis of impaired follicle-stimulating hormone action: evidence from human mutations and mouse models. Reprod. Sci. 2012.
83. Sim H., Argentaro A., Harley V.R. Boys, girls and shuttling of SRY and SOX9. Trends Endocrinol. Metab. 2008, 19:213-222.
84. Smith E.P., Boyd J., Frank G.R., Takahashi H., Cohen R.M., Specker B., et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med. 1994, 331:1056-1061.
85. Smits G., Olatunbosun O., Delbaere A., Pierson R., Vassart G., Costagliola S. Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. N. Engl. J. Med. 2003, 349:760-766.
86. Spielman R.S., Ewens W.J. The TDT and other family-based tests for linkage disequilibrium and association. Am. J. Hum. Genet. 1996, 59:983-989.
87. Strobel A., Issad T., Camoin L., Ozata M., Strosberg A.D. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat. Genet. 1998, 18:213-215.
88. Sultan C., Biason-Lauber A., Philibert P. Mayer-Rokitansky-Kuster-Hauser syndrome: recent clinical and genetic findings. Gynecol. Endocrinol. 2009, 25:8-11.
89. Sykiotis G.P., Plummer L., Hughes V.A., Au M., Durrani S., Nayak-Young S., et al. Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. Proc. Natl. Acad. Sci. USA 2010, 107:15140-15144.
90. Tobet S.A., Schwarting G.A. Minireview: recent progress in gonadotropin-releasing hormone neuronal migration. Endocrinology 2006, 147:1159-1165.
91. Tomlinson I.P., Alam N.A., Rowan A.J., Barclay E., Jaeger E.E., Kelsell D., et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat. Genet. 2002, 30:406-410.
92. Topaloglu A.K., Reimann F., Guclu M., Yalin A.S., Kotan L.D., Porter K.M., et al. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction. Nat. Genet. 2009, 41:354-358.
93. Topaloglu A.K., Tello J.A., Kotan L.D., Ozbek M.N., Yilmaz M.B., Erdogan S., et al. Inactivating KISS1 mutation and hypogonadotropic hypogonadism. N. Engl. J. Med. 2012, 366:629-635.
94. Tornberg J., Sykiotis G.P., Keefe K., Plummer L., Hoang X., Hall J.E., et al. Heparan sulfate 6-O-sulfotransferase 1, a gene involved in extracellular sugar modifications, is mutated in patients with idiopathic hypogonadotrophic hypogonadism. Proc. Natl. Acad. Sci. USA 2011, 108:11524-11529.
95. Treloar S.A., Wicks J., Nyholt D.R., Montgomery G.W., Bahlo M., Smith V., et al. Genomewide linkage study in 1176 affected sister pair families identifies a significant susceptibility locus for endometriosis on chromosome 10q26. Am. J. Hum. Genet. 2005, 77:365-376.
96. Uno S., Zembutsu H., Hirasawa A., Takahashi A., Kubo M., Akahane T., et al. A genome-wide association study identifies genetic variants in the CDKN2BAS locus associated with endometriosis in Japanese. Nat. Genet. 2010, 42:707-710.
97. Urbanek M., Legro R.S., Driscoll D.A., Azziz R., Ehrmann D.A., Norman R.J., et al. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc. Natl. Acad. Sci. USA 1999, 96:8573-8578.
98. Vasseur C., Rodien P., Beau I., Desroches A., Gerard C., de Poncheville L., et al. A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. N. Engl. J. Med. 2003, 349:753-759.
99. Vissers L.E., van Ravenswaaij C.M., Admiraal R., Hurst J.A., de Vries B.B., Janssen I.M., et al. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat. Genet. 2004, 36:955-957.
100. Vockley J., Rinaldo P., Bennett M.J., Matern D., Vladutiu G.D. Synergistic heterozygosity: disease resulting from multiple partial defects in one or more metabolic pathways. Mol. Genet. Metab. 2000, 71:10-18.
101. Weiss J., Axelrod L., Whitcomb R.W., Harris P.E., Crowley W.F., Jameson J.L. Hypogonadism caused by a single amino acid substituion in the β subunit of luteinizing hormone. N. Engl. J. Med. 1992, 326:179-183.
102. Xu, N., Kim, HG., Bhagavath, B., Cho, S.G., Lee, J.H., Ha, K., et al., 2011. Nasal embryonic LHRH factor (NELF) mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome. Fertil. Steril.
103. Yanase T., Simpson E.R., Waterman M.R. 17-Alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr. Rev. 1991, 12:91-108.
104. Young J., Metay C., Bouligand J., Tou B., Francou B., Maione L., et al. SEMA3A deletion in a family with Kallmann syndrome validates the role of semaphorin 3A in human puberty and olfactory system development. Hum. Reprod. 2012, 27:1460-1465.
105. Zhao H., Chen Z.J., Qin Y., Shi Y., Wang S., Choi Y., et al. Transcription factor FIGLA is mutated in patients with premature ovarian failure. Am. J. Hum. Genet. 2008, 82:1342-1348.
106. Zhong Q., Layman L.C. Genetic considerations in the patient with Turner syndrome-45,X with or without mosaicism. Fertil. Steril. 2012, 98:775-779.
107. Zhou J., Mochizuki T., Smeets H., Antignac C., Laurila P., de Paepe A., et al. Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors. Science 1993, 261:1167-1169.